zy03_0611 Gland Packing(extract) Table for Selection of Non-Asbestos Gland Packing for Valve Stems Gland Packing : Critical Specification : Products containing PFAS : Recommended products : Combination recommended products : For adapter packing only No.81331 No.6232 VALQUA No.

Information of PFAS and PFAS present in mixtures and articles Identity and quantity Please fill in the following table in the columns relevant to you with the respective information concerning your PFAS/precursor/perfluorinated precursor.

Recycling and End of life assessment of Fluoropolymers: Recent Developments, Challenges and Future Trends Bruno Ameduri*,1 Hisao Hori,2 l ICGM, University of Montpellier, CNRS, ENSCM, 34095 Montpellier, France.

Old PTFE membrane Projects list Region Project Japan USA Europe Other Tokyo Dome Intex Osaka Nagai athletics Field University of La Verne Asheboro Zoo Walden Galleria mall Tropicana Field Denver International Airport Schlumberger Cambridge Research Center UK O2 ArenaUK Rome Olympic StadiumItaly The Hajj TerminalSaudi Arabia Completion year (years) 198835years 198538years 199627years 197350years 198340years 198835years 198934years 199430years 198439years 199825years 199033years 198142years

Pigment Yellow 154 Hostaperm Yellow H3G 02 Pigment Yellow 154 Pigments of the Hostaperm range are organic, high-performance pigments mainly used in Coatings applications.

AR226-2129 file;///C|/WlNDOWS/TEMP/M) C-81-3-79 (hu 4-30-811 page-htm Test Results Sample Data Range Concentration Ranflft Action Lovel Industrial Hygiene 1/3/79 400/61 100% SamptaBt Samples Duration Type Employee Namo Pers BTO: LOC: 17 RESEARCH 019 WEIGH AND ADD C-8 TO POLYKETTLE 1/3/79 47591 Z Chemical C-8 1/4/79 47S32 2 0.8 Cone Unit Percont 0.05 PPM <0.05 PPM 0.0% 0.0% BTO: 17 RESEARCH tOC; 065 PPDSEMIWORKS 4/8/81 57356 Z C-B <0.0001 PPM 0.0% BTO: 17 RESEARCH LOC: 100 P/S-EPM WAREHOUSE -FORK TRUCK OPERATION 4/30/81 60221 Z C*8 0.0001 PPM 0.0% BTO: LOC!

AR226-2248 Thompson Colllns WatMns Smith Name Concentrations are from the deposition modeling runs, and include wet and dry depletion due to deposition Coordinates Paniculate Deposition (g/m'/yr) Vapor Deposition (g/m'/yr) Total Deposition (fl/m'/vr) 445213E 4346090N 443141E 4345753N 4432236 4345847N 443254E 434588SN 0,00098 0.00179 0.00193 0.00186 0.00008 0.00021 0.00019 0.00018 0.00106 0.00200 0.00212 0.00204 (I Particulate Vapor Total Concentration Concentration Concentration (ua/rn3)____(uaftn3)____(ug/nr'l 0.02000 0.03217 0.05217 0.03752 0.05854 0.09606 0.03665 0.05695 0.09360 0.03554 0.055B7 0.09141

AR226-2381 C8 EMVIROKMEMTAL STATUS History "Industrial Hygiene Engineering Changes Protective Equipment Air Monitoring Blood.

Annex II - Study of the University of Sevilla (Spain) Internal space gains and CO2 emissions savings in building renovations with Solstice insulation technology White Paper Honeywell/ Internal space gains and CO2 emissions savings in building renovations with Solstice insulation technology 1.

Consultation on ECHA's proposal to restrict the production, placing on the market and use of per- and polyfluoroalkyl substances (PFAS) This document is to comment on the public consultation on a proposed restriction on the production, marketing and use of per- and polyfluoroalkyl substances (PFAS). 1.

FOR DU FONT USE OSLY Copies t AR226-2897 E* I* du Font de Neoours and Company Haskell Laboratory for Toxicology and Industrial Medicine Elkton Road, Newark, Delaware 19711 HASKELL LABORATORY REPORT NO. 256-81 MR SO Haskell So. 14.008 Other Codes Study Initi&ced/Completed 4/6/81 - 4/20/81------ Material S Lyner Products Department Experimental Station EYE IRRITATION TEST IS RABBITS Procedure; One-tenth milliliter (71 og) of solid test material was placed into the right conjunctlval sac > each of 2 male New Zealand White rabbits.

AR226-3117 CONFIDENTIAL DPT441/984973 ALGAL GROWTH INHIBITION ASSAY Sponsor DuPont Speciality Chemicals, Jackson Laboratory, Chambers Works, Deepwater, NJ 08023, USA.

.0 3 Department for Environment Food & Rural Affairs GB F-gas Review Agenda 1) Update on the GB F-gas review 2) Policy development - considerations and discussion 3) Other questions 2 GB F-gas Review - consultation Objectives Domestic commitment for net zero Compliance with our international obligations Supporting wider government aims Progress Ongoing policy development and supporting analysis Next steps Draft consultation with proposals for changes Launch consultation Government response Legislate for changes Implement GB new F-gas Regulation 3 Policy development Considerations Ongoing transition to lower GWP propellants MHRA approvals and associated prep work Engagement with industry suggests transition of existing MDIs portfolios will take until at least 2030 MDI manufacturing and MDI supply/use in GB Interactions with NHS action Impact on patient access to medicine 4 Policy development Broad options Removal of the exemption from quota Existing phasedown and quota system Quota and quota authorisations Timeframes Placing on the market prohibitions GWP limit Charge size 5 Policy development Possible criteria for quota exemption, at specific time point: 1.

We'll review the updated draft Regulation 61 document and contact you separately on this.